SW, M., KC, M., B, B., C, G., AD, K., M, K., & AJ, W. (2024). Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association, 45(3), 808. https://doi.org/10.1093/jbcr/irae026
Chicago Style (17th ed.) CitationSW, Mueller, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, and Wiktor AJ. "Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas Aeruginosa." Journal of Burn Care & Research : Official Publication of the American Burn Association 45, no. 3 (2024): 808. https://doi.org/10.1093/jbcr/irae026.
MLA (9th ed.) CitationSW, Mueller, et al. "Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas Aeruginosa." Journal of Burn Care & Research : Official Publication of the American Burn Association, vol. 45, no. 3, 2024, p. 808, https://doi.org/10.1093/jbcr/irae026.